May 17, 2017
Nicox welcomes new Board member
Nicox, the international ophthalmic R&D company, appointed Lauren P. Silvernail to the its Board of Directors, for a period of four years.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
May 16, 2017
New York county sues Purdue, J&J over opioid marketing
A county in New York state has sued Purdue Pharma LP, Johnson & Johnson <JNJ.N> and other drugmakers, accusing them of engaging in fraudulent marketing that played down the risks of prescription opioid painkillers, leading to a drug epidemic.
May 16, 2017
Advent, Shanghai Pharma have not approached Stada – sources
German drug company Stada Arzneimittel AG has not been approached by Advent International or Shanghai Pharmaceuticals Holding with a counter offer, two sources close to the matter told Reuters on Monday.
May 15, 2017
US District Court upholds Horizon Pharma’s patent
The United States District Court for the District of New Jersey upheld the validity of Horizon Pharma’s patent covering Pennsaid (diclofenac sodium topical solution) 2% w/w, which Actavis Laboratories UT, Inc.(Actavis) has admitted that its proposed generic diclofenac sodium topical solution product would infringe.
May 15, 2017
Mereo BioPharma wraps up patients testing for its rare pulmonary disease drug
Mereo BioPharma Group, a clinical stage, biopharmaceutical company focused on rare and specialty diseases, has completed patient enrolment in the AETHER, multi-centre, double-blind, placebo-controlled Phase 2 dose-ranging study of acumapimod (BCT-197), for the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
May 12, 2017
WHO wants transparency, market revamp for fairer drug pricing
The world needs greater transparency on the pricing of medicines, and an overhaul of some approaches, in order to increase access to life-saving drugs, global health experts said on Thursday.
May 12, 2017
AstraZeneca’s cancer drug shows positive result in NSCLC treatment
AstraZeneca and its subsidiary MedImmune, have reported positive results for the Phase III PACIFIC trial, a randomised, double-blinded, placebo-controlled multi-centre trial of Imfinzi (durvalumab) as sequential treatment in patients with locally-advanced, unresectable (Stage III) non-small cell lung cancer (NSCLC) who had not progressed following standard platinum-based chemotherapy concurrent with radiation therapy.
May 11, 2017
Stada reports net income 33% up net income, recommends shareholders to accept takeover offer
Stada Arzneimittel has reported adjusted net income of €53.3 million for the first quarter of 2017 which is 33% increase compared to last years net income of €40.1 million.
May 11, 2017
Catalyst Pharmaceuticals reports $4.9M loss for Q1 2017
Catalyst Pharmaceuticals has reported a GAAP net loss of $4.9 million for first quarter of 2017, compared to a GAAP net loss of $5,4 for the same period in 2016.
May 10, 2017
Lilly welcomes new member of executive committee
Leigh Ann Pusey will join Eli Lilly as senior vice president of corporate affairs and communications, effective June 12, 2017. She will be a member of Lilly’s executive committee reporting directly to president and chief executive officer, David A. Ricks.